gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

Machine learning-based prediction model for treatment of acromegaly with first-generation somatostatin receptor ligands

(2021) Luiz Eduardo Wildemberg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective

(2021) Federica Nista et al.   Frontiers in Endocrinology

Octreotide-Resistant Acromegaly: Challenges and Solutions

(2020) Giuliana Corica et al.   Therapeutics and Clinical Risk Management

PREDICTIVE MARKERS FOR POST-SURGICAL MEDICAL MANAGEMENT OF ACROMEGALY: A SYSTEMATIC REVIEW AND CONSENSUS TREATMENT GUIDELINE

(2019) Shereen Ezzat et al.   Endocrine Practice

Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles

(2019) Maria Caroline Alves Coelho et al.   Scientific Reports

MEDICAL THERAPY FOR ACROMEGALY: TOWARDS THE PRACTICE OF A PERSONALIZED MEDICINE APPROACH

(2019) Kevin C. J. Yuen   Endocrine Practice

Precision medicine in the treatment of acromegaly

(2019) Manuel Puig-Domingo et al.   Minerva Endocrinologica

MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly

(2018) Leandro Kasuki et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Molecular evidence and clinical importance of β-arrestins expression in patients with acromegaly

(2018) Maria Caroline Alves Coelho et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center

(2018) Ming Shen et al.   World Neurosurgery

The genetic background of acromegaly

(2017) Mônica R. Gadelha et al.   Pituitary

Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly

(2016) Federico Gatto et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

A paradigm shift in the medical treatment of acromegaly: from a ‘trial and error’ to a personalized therapeutic decision-making process

(2015) Mônica R. Gadelha   CLINICAL ENDOCRINOLOGY

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

(2015) Donato Iacovazzo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification

(2015) Alexander S. G. Micko et al.   JOURNAL OF NEUROSURGERY

Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis

(2015) Z. A. Efstathiadou et al.   Pituitary

Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly

(2015) Annamaria Colao et al.   Pituitary

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement

(2015) Erika Peverelli et al.   Frontiers in Endocrinology

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas

(2013) Sarah Larkin et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly

(2012) Federico Gatto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel pathway for somatostatin analogs in patients with acromegaly

(2012) Mônica R. Gadelha et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly

(2011) Stine Lyngvi Fougner et al.   CLINICAL ENDOCRINOLOGY

Impact of gsp Oncogene on the mRNA Content for Somatostatin and Dopamine Receptors in Human Somatotropinomas

(2010) Giselle Fernandes Taboada et al.   NEUROENDOCRINOLOGY

Somatostatin receptors subtypes 2 and 5, dopamine receptor type 2 expression and gsp status as predictors of octreotide LAR® responsiveness in acromegaly

(2009) Leonardo Vieira Neto et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form

(2008) Abdulkader Obari et al.   ENDOCRINE PATHOLOGY